Quantcast

Latest ADHD Stories

2014-07-17 16:25:39

LEXINGTON, Massachusetts, July 17, 2014 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPG) today announced top-line results from two Phase 4 efficacy and safety studies of Vyvanse(R) (lisdexamfetamine dimesylate) compared with Concerta (methylphenidate HCl) with a placebo reference arm in adolescents aged 13-17 diagnosed with Attention-Deficit/Hyperactivity Disorder (ADHD). In SPD489-406, the forced-dose titration study, Vyvanse was found to be statistically superior to...

2014-07-10 10:28:40

Boston Children's Hospital Study calls for more focus on long-term outcomes in pediatric trials of drugs intended for chronic use Over the last 60 years, the U.S. Food and Drug Administration (FDA) approved 20 medications for attention deficit/hyperactivity disorder (ADHD) based on clinical trials that were not designed to study their long-term efficacy and safety or to detect rare adverse events, researchers at Boston Children's Hospital report today in PLOS ONE. The study highlights...

2014-07-09 16:28:10

Study calls for more focus on long-term outcomes in pediatric trials of drugs intended for chronic use BOSTON, July 9, 2014 /PRNewswire-USNewswire/ -- Over the last 60 years, the U.S. Food and Drug Administration (FDA) approved 20 medications for attention deficit/hyperactivity disorder (ADHD) based on clinical trials that were not designed to study their long-term efficacy and safety or to detect rare adverse events, researchers at Boston Children's Hospital report today in PLOS...

2014-07-09 08:27:34

LOS ANGELES, July 9, 2014 /PRNewswire/ -- NeuroSigma, Inc. (NeuroSigma), a California-based life sciences company focused on commercialization of its non-invasive Monarch(TM) eTNS(TM) System for the treatment of neurological and neuropsychiatric disorders, today announced that the U.S. National Institutes of Health (NIH) has awarded UCLA a grant that funds a Phase II 90-subject pediatric clinical trial at the University of California, Los Angeles (UCLA) focused on the treatment of...

2014-07-03 12:51:53

University of Copenhagen Researchers at the University of Copenhagen and the Copenhagen University Hospital have identified a particular genetic mutation that may cause parkinsonism in young people. The mutation interferes with the brain's transport of the important signal substance dopamine and may also plays a role in mental diseases, e.g. ADHD. The findings have just been published in the scientific Journal of Clinical Investigation. Being one of the most important signal substances...

2014-07-02 23:06:10

BCC Research (http://www.bccresearch.com) is pleased to announce the BCC Research Strattera® Forecast, a strategic investment product designed to provide market data for the pharmaceutical drug, Strattera®, a treatment for Attention Deficit Hyperactivity Disorder (ADHD) distributed by Eli Lilly and Company. Strattera® will lose its branded patent protection in late 2016 going into 2017, opening the market to distribution of generic treatments by competing companies....

2014-07-02 23:01:05

Harbor Village Florida comments on a new report that shows that ADHD is likely to lead to drug abuse. USA (PRWEB) July 02, 2014 As reported by CBS News in the article Kids with ADHD More Likely to Abuse Drugs (6/30), a recent study has linked increased rates of substance abuse among kids who grow up with ADHD while dismissing the fact that traditional ADHD medicine has a role in it. While researchers do not have an exact answer as to why there is a higher chance of drug abuse among this...

2014-06-30 23:19:59

Dr. Tim Houchin, M.D., founder and president of 360 Mental Health Services, was featured on Kentucky Educational Television's Connections, a television show hosted by Renee Shaw that highlights individuals striving to make a difference in the community. During the half-hour program Dr. Houchin addressed a wide range of mental health related questions, including possible reasons Kentucky now leads the country in the diagnosis of ADHD in children at some 19 percent. Lexington, Kentucky...

2014-06-30 23:07:01

Developers and marketers of innovative ACTIVATE cognitive cross training program offers educators a dynamic new portal for helping children with ADHD in the classroom. New Haven, CT (PRWEB) June 30, 2014 C8 Sciences, developers and marketers of the industry-transforming ACTIVATE neuroscience-based cognitive cross training program designed to battle ADHD in the classroom, announced the launch C8Schools.com. The site is dedicated to showcasing the benefits of the ACTIVATE Education protocol...

2014-06-24 23:14:59

Recent studies reporting the rising incidences of Autism (ASD), ADHD and Dyslexia are primarily due to better recognition and diagnosis of milder cases, states neuropsychiatrist Dr. Harold Levinson. Great Neck, New York (PRWEB) June 24, 2014 A recent study just released by the Center for Disease Control (CDC) notes that the incidence of Autism or ASD rose 30% in just two years from 1/88 to 1/68. Another CDC report indicated that ADHD just increased to 11% from 8%. Similarly, the...


Word of the Day
penuche
  • A fudgelike confection of brown sugar, cream or milk, and chopped nuts.
'Penuche' is a variant of 'panocha,' a coarse grade of sugar made in Mexico. 'Panocha' probably comes from the Spanish 'panoja, panocha,' ear of grain.
Related